Skip to main content
Premium Trial:

Request an Annual Quote

Peter Wilver, Stephen Williamson

Thermo Fisher Scientific said that CFO Peter Wilver will retire, effective March 31, 2016. The firm's board of directors has named Stephen Williamson, currently VP of financial operations, to become the new CFO, effective Aug. 1, 2015. Wilver joined the firm in 2004 as CFO, and during his tenure the company's market cap grew from $5 billion to around $50 billion today, President and CEO Marc Casper noted in a statement.

Williamson joined Thermo Fisher in 2001 as VP of European financial operations, based in the UK, and subsequently served as the finance lead for the Informatics and Services, and the Environmental Instruments businesses. He was named VP of finance for Analytical Technologies in 2006, and two years later became VP of financial operations for the company. 

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.